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Recovery of Mycobacterium tuberculosis from sputa treated with cetyl-pyridinium chloride (CPC) and stored
for 20  9 days was signiﬁcantly higher than that from sputa that were untreated and processed by the
N-acetyl-L-cisteine–NaOH method. Addition of CPC is useful for isolation of M. tuberculosis from sputa
subjected to long-term storage received from remote areas of the world.
Tuberculosis (TB) remains one of the major public health
problems worldwide, with 95% of cases and 98% of deaths
occurring in developing countries (9). The transportation of
sputa for culture for Mycobacterium tuberculosis from these
countries to laboratories located abroad usually takes more
than one week and results in an increased contamination rate
and a loss of positive cultures. This is due to several factors,
including inadequacy of refrigeration and a lack of preservative
addition.
In previous studies, cetyl-pyridinium chloride (CPC), a sub-
stance known to kill pathogenic fungi from sputum specimens
(4), was shown to increase the culture positivity and reduce the
contamination rate (1, 6–7) in sputa cultured on solid media
after 8 days (6–7) or 2 weeks (1, 8) from collection, in com-
parison with the N-acetyl-L-cisteine–NaOH (NALC) decon-
tamination method (3). An advantage of the CPC method is
that specimens can be decontaminated during mail shipment
when processing is to be delayed. In this study we examined the
effect of CPC on the recovery of M. tuberculosis from sputa
subjected to long-term storage in comparison with CPC-un-
treated sputa collected from the same patients and processed
by the NALC method. Such a long period between sputum
collection and culture may occur in places where transporta-
tion from the collection site is subject to heavy logistic con-
straints and samples are gathered to limit the cost of shipment.
A total of 276 sputum samples were collected at Guliripchi
Tuberculosis Hospital, Sukhumi, Abkhazia, a region of the
former Soviet Union along the Black Sea coast, from March
2003 to November 2003. For each patient, two sputum samples
were collected on two consecutive days, but to only one was
added an approximately equal volume of a CPC (Sigma, St.
Louis, Mo.) solution (ﬁnal concentration [f.c.]: CPC, 0.5%;
NaCl, 1%;) (2). At Guliripchi Hospital, smear microscopy by
the Ziehl-Neelsen method (2, 3) was performed on all uncon-
centrated specimens. CPC was added randomly to either the
ﬁrst or second specimen from the same patient. Sputa were
kept refrigerated at 4°C and mailed by a courier in groups of
20 to 30 sputa per parcel to the Istituto Superiore di Sanita `,
Rome, for culture; overall, the mean time between collection
and sample processing was 20  9 days (range, 7 to 36 days).
CPC-treated sputa (approximately 3 ml of sputum and 3 ml of
CPC) were added with Bacto neutralizing buffer (Difco, De-
troit, Mich.) to inactivate residual CPC (2) up to a 30-ml
volume in a 50-ml Falcon tube and centrifuged at 3,000  g for
30 min at room temperature, and the sediment was inoculated
in Lowenstein-Jensen (LJ) slants (100 l) (Biome ´rieux, Marcy
l’Etoile, France) and Middlebrook 7H10 (7H10) (Difco) plates
(100 l). The non-CPC-treated sputa were processed by the
NALC method, using a commercial kit (MycoPrep; Becton
Dickinson, Cockeysville, Md.) (1% NaOH, f.c.), and the sedi-
ment was suspended in phosphate-buffered saline and inocu-
lated in LJ and 7H10 media. An aliquot of each sediment was
frozen at 80°C; if the ﬁrst cultures of CPC- and/or NALC-
treated sputa were contaminated, the frozen aliquot was
thawed and submitted to a retreatment with NaOH alone (2%,
f.c.) for 15 min at room temperature, diluted with phosphate-
buffered saline, and centrifuged, and the sediments (100 l)
were plated on LJ and 7H10 media. The LJ and 7H10 media
were incubated at 37°C in 5% CO2 and examined weekly for 8
weeks. M. tuberculosis was identiﬁed in positive cultures by a
DNA-RNA hybridization (Accuprobe; Gene Probe, San Di-
ego, Calif.) (3).
Treatment of the sputa with CPC signiﬁcantly increased the
rate of positive M. tuberculosis cultures (from 47.1 to 63.8% for
NALC and CPC, respectively; P  0.05, Fisher’s exact test)
and decreased the contamination rate (from 42.0 to 21.0% for
NALC and CPC, respectively; P  0.01); the negative cultures
were 10.9 and 15.2% for NALC and CPC, respectively. After
retreatment of the contaminated sputa with NaOH, overall
positivity (positivity after the ﬁrst culture plus positivity after
retreatment) of CPC-treated samples was signiﬁcantly higher
than that for samples processed with the NALC method (78.3
and 65.9%, respectively; P  0.05); the contamination rate was
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 very low (2.2 and 3.6%, respectively), and the rates of negative
cultures were 30.4 and 19.5% for CPC and NALC, respec-
tively. These observations indicated that the yield of positive
cultures in sputa subjected to long-term storage is higher in
samples collected with CPC than in those collected without the
addition of this substance; these results are in keeping with
those of previous reports (1, 6–8) but extend them to a time
period longer than those previously described.
To evaluate the effect of CPC and NALC methods on M.
tuberculosis viability, smear scores and overall culture results
obtained after the second decontamination steps were com-
pared (Table 1). The data showed that while 4,3 ,2 ,o r
1 smear-positive CPC- or NALC-processed sputa did not
signiﬁcantly differ in culture positivity, for those reported as
negative or doubtful, which should contain fewer than 5,000 to
10,000 organisms per ml (3), culture positivity was signiﬁcantly
higher for CPC-treated (48.3%) than for NALC-treated
(19.3%) sputa (P  0.05, Fisher’s exact text). To verify whether
the quality of the specimen could affect the sensitivity of the
method, a statistical analysis was performed including only the
patients from which sputa with identical smear results were
obtained; also, in this case, culture positivity of smear-negative
(or doubtful) sputa collected with CPC was statistically higher
than that of sputa collected without CPC (P  0.03, McNemar
binomial test for paired samples). These observations indi-
cated that in samples containing relatively low numbers of
mycobacterial cells, CPC preserves M. tuberculosis viability to
an extent signiﬁcantly higher than that with NALC. From the
clinical point of view, this is very important for diagnosis and
treatment adaptation, because smear-negative patients have a
2.5-times-higher chance of having a positive culture result if
sputa are collected with CPC (95% conﬁdence interval, 1.1 to
5.6; Epi Info 6.04 [Centers for Disease Control, Atlanta, Ga.]).
Also, in 1 to 4 smear-positive, culture-positive samples,
CPC-treated sputa had higher positivity rates than those with
NALC, even if the differences did not reach a signiﬁcant level.
Among 1,2  and 3 smear-positive samples, 26% in the
CPC group (13 out of 50) and 28.2% in the NALC group (20
out of 71) were culture negative; of these, 77.9% (10 out of 13)
and 55% (11 out of 20) in the CPC and NALC groups, respec-
tively, were collected from patients on anti-TB treatment, who
are known to harbor nonviable M. tuberculosis bacilli; these
percentages are in agreement with those reported during fol-
low-up of TB treatment (5). A total of eight patients on an-
ti-TB treatment overlapped among the culture-negative sam-
ples from the CPC and NALC groups. Nonviable M.
tuberculosis cells or CPC-susceptible mycobacteria other than
M. tuberculosis organisms were probably present in the remain-
ing (3 out of 13) smear-positive, culture-negative sputa treated
with CPC.
Overall, our observations indicated that CPC is a satisfactory
preservative for mailing sputa for TB diagnostics because it
decontaminates specimens collected in remote areas of the
world and increases the yield of positive cultures after 20 days
or longer.
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